Order Article Reprints

Robles C, Rudzite D, Polaka I, Sjomina O, Tzivian L, Kikuste I, Tolmanis I, Vanags A, Isajevs S, Liepniece-Karele I, et al. Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study. Diagnostics. 2022; 12(7):1746. https://doi.org/10.3390/diagnostics12071746

Robles, Claudia, Dace Rudzite, Inese Polaka, Olga Sjomina, Lilian Tzivian, Ilze Kikuste, Ivars Tolmanis, Aigars Vanags, Sergejs Isajevs, Inta Liepniece-Karele, and et al. 2022. "Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study" Diagnostics 12, no. 7: 1746. https://doi.org/10.3390/diagnostics12071746

Robles, C., Rudzite, D., Polaka, I., Sjomina, O., Tzivian, L., Kikuste, I., Tolmanis, I., Vanags, A., Isajevs, S., Liepniece-Karele, I., Razuka-Ebela, D., Parshutin, S., Murillo, R., Herrero, R., Young Park, J., & Leja, M. (2022). Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study. Diagnostics, 12(7), 1746. https://doi.org/10.3390/diagnostics12071746